Literature Metrology and Visualization Analysis of Global Randomized Controlled Experiments on Polycystic Ovary Syndrome from 2019 to 2024

目的：分析近6年多囊卵巢综合征随机对照研究特点，为临床应用和未来研究提供参考。方法：检索2019~2024年发表在Web of Science的多囊卵巢综合征随机对照研究，对文献基本要素开展计量学分析。结果：共纳入204篇随机对照研究，尽管2023年相关文献较少，近6年多囊卵巢综合症相关随机对照研究年度发文趋势较为稳定，平均年度发文量为34篇。发文量最多的为中科院分区生殖生物学2区杂志《JOURNAL OF OVARIAN RESEARCH》，近6年共计发表PCOS相关RCT研究10篇。影响因子最高的杂志为《LANCET DIABETES & ENDOCRINOLOGY》，目前影响因子为44分。并进一步对主要结局指标和主要干预措施进行可视化分析。Aim: Analyze the characteristics of randomized controlled studies of polycystic ovary syndrome in the past 6 years, which provides reference for clinical application and future research. Methods: Retrieve the randomized controlled study of polycystic ovary syndrome published in the Web of Science from 2019 to 2024, and carried out a metric analysis of the basic elements of the literature. Results: A total of 204 randomized controlled studies were included. Although there were fewer relevant literature in 2023, the annual trend of published randomized controlled studies on polycystic ovary syndrome in the past 6 years was relatively stable, with an average annual published volume of 34 articles. The largest number of articles is “JOURNAL OF OVARIAN RESEARCH”, a journal of distinct 2 of reproductive biology of the Chinese academy of science, which has published a total of 10 PCOS-related RCT research in the past six years. The journal with the highest impact factor is “LANCET DIABETES & ENDOCRINOLOGY”, with a current impact factor of 44 points. And further visualize and analyze the main outcome indicators and main interventions.